Search research articles
Contact Us
Filters
Showing results (171-180 of 189) with videos related to
Page
of 19
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
October 12, 2000
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers
E Jäger, S Gnjatic, Y Nagata, et al.
International Journal of Cancer
|
October 3, 1999
Antigens recognized by autologous antibody in patients with renal-cell carcinoma
M J Scanlan, J D Gordan, B Williamson, et al.
Scandinavian Journal of Immunology
|
September 1, 1996
Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma
H Bernhard, M J Maeurer, E Jäger, et al.
European Cells & Materials
|
September 19, 2019
Collagen type X is essential for successful mesenchymal stem cell-mediated cartilage formation and subsequent endochondral ossification
C A Knuth, E Andres Sastre, N B Fahy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 27, 2000
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele
S Gnjatic, Y Nagata, E Jager, et al.
Annals of Hematology
|
May 25, 2004
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia
W K Hofmann, G Heil, C Zander, et al.
British Journal of Cancer
|
September 11, 2003
Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial
C-H Köhne, R Catane, B Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2004
Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group
E Laack, N Dickgreber, T Müller, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 26, 2000
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses
E Jäger, Y Nagata, S Gnjatic, et al.
Cancer Science
|
March 1, 2008
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome
M Tinguely, B Jenni, A Knights, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 189) with videos related to
Sort By:
Page
of 19
Proceedings of the National Academy of Sciences of the United States of America
|
October 12, 2000
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers
E Jäger, S Gnjatic, Y Nagata, et al.
International Journal of Cancer
|
October 3, 1999
Antigens recognized by autologous antibody in patients with renal-cell carcinoma
M J Scanlan, J D Gordan, B Williamson, et al.
Scandinavian Journal of Immunology
|
September 1, 1996
Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-gamma
H Bernhard, M J Maeurer, E Jäger, et al.
European Cells & Materials
|
September 19, 2019
Collagen type X is essential for successful mesenchymal stem cell-mediated cartilage formation and subsequent endochondral ossification
C A Knuth, E Andres Sastre, N B Fahy, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 27, 2000
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele
S Gnjatic, Y Nagata, E Jager, et al.
Annals of Hematology
|
May 25, 2004
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia
W K Hofmann, G Heil, C Zander, et al.
British Journal of Cancer
|
September 11, 2003
Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial
C-H Köhne, R Catane, B Klein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2004
Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group
E Laack, N Dickgreber, T Müller, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 26, 2000
Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses
E Jäger, Y Nagata, S Gnjatic, et al.
Cancer Science
|
March 1, 2008
MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome
M Tinguely, B Jenni, A Knights, et al.
Page
of 19